Lactose: Clinical Trials

125 trials of Lactose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

88 completed, 15 unknown, 11 terminated, 5 recruiting. 36 Phase 2, 33 Not applicable, 24 Phase 4, 17 Phase 3, 14 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 236Completed 23, Unknown 6, Terminated 4, Active not recruiting 1, Recruiting 1, Withdrawn 1
Not applicable33Completed 22, Terminated 4, Unknown 3, Withdrawn 2, Active not recruiting 1, Recruiting 1
Phase 424Completed 18, Recruiting 3, Unknown 2, Terminated 1
Phase 317Completed 11, Unknown 4, Terminated 2
Phase 114Completed 13, Terminated 1
Early Phase 14Completed 2, Not yet recruiting 1, Terminated 1

Follow Lactose: new trials by email Literature Review of Lactose trials Research Report on Lactose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Cerebrovascular Blood Flow and Sex Differences in Metabolic Syndrome
Indomethacin, Placebo, MRI - Metabolic Syndrome
Early Phase 1Not yet recruitingUniversity of Wisconsin, Madison722026-10-012026-09-29
Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers
Synbiotic Supplement, Lactose (inactive placebo) - Gastrointestinal Tolerance of Probiotics in Infants
Not applicableCompletedPersephone Biosciences1102025-01-012026-08-25
Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis
complete, polymeric formula, fiber, lactose and gluten free - Juvenile Idiopathic Arthritis (JIA)
Not applicableRecruitingMeyer Children's Hospital IRCCS202024-12-122025-03-13
Testing the Capability of the Smart Underwear Device to Detect Increased Microbiome Activity Following Lactose Consumption
Lactose, Sucrose, Wear smart underwear - Lactose Intolerance, Adult Type
Not applicableCompletedUniversity of Maryland, College Park372024-12-052026-05-01
Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty
Vitamin C, Placebo - Chronic Pain, Knee Pain Chronic
Phase 2RecruitingUniversity Health Network, Toronto4002024-04-162026-06-23
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
Methylphenidate, Placebo - Epilepsy
Phase 4RecruitingVA Office of Research and Development2262023-08-142026-04-20
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
Caffeine (200 mg), Placebo - Healthy, Caffeine
Phase 4RecruitingHsiao-Ying Wey122023-05-172025-01-09
The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury
Colchicine, Placebo (lactose) - Reperfusion Injury, Myocardial
Phase 3UnknownUniversitas Indonesia802022-12-042023-02-21
Study Design of the Diacerein in Patients With Covid-19
Diacerein, placebo capsules - COVID-19
Phase 2UnknownUniversity of Campinas, Brazil402022-04-012022-08-02
Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery
Melatonin 10 MG, Lactose pill - Pain, Postoperative, Narcotic Use
Phase 2CompletedMontefiore Medical Center602021-11-162026-01-30
Role of Strontium Ranelate in Proximal Femur Fragility Fractures.
Strontium Ranelate, Lacto-N-Hexaose - Fragility Fracture, Femur; Fracture, Pertrochanteric
Phase 4UnknownAga Khan University Hospital, Pakistan1002021-11-012023-02-03
Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim
Placebo (Lactose) Capsule, 0.75 mg Alprazolam Capsule, Cannabis (6.18% THC / <0.025% CBD) - Driving Behavior, Driving Under the Influence
Phase 1CompletedTimothy L. Brown132021-07-162023-07-25
Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries
Sildenafil Citrate, Placebo - Spinal Cord Injuries, Urinary Incontinence
Phase 2Active not recruitingThe University of Texas Medical Branch, Galveston242021-07-072026-09-09
Effect of Lactose on Blood Lipids
Maltodextrin, Sucrose, Lactose - Cardiovascular Risk Factor, Lipaemia
Not applicableCompletedUniversity of Bath262021-06-072024-09-23
Acetazolamide Efficacy in Ataxia in PMM2-CDG
Placebo, Acetazolamide - Pmm2-CDG, CDG1A
Phase 2 / Phase 3TerminatedMayo Clinic252021-03-172025-03-20
Low-FODMAP vs Lactose-Gluten-Free Diet in Patients With Irritable Bowel Syndrome
Low-FODMAP Diet, Lactose- and Gluten-Free Diet - Irritable Bowel Syndrome
Not applicableCompletedAntalya Bilim University722020-09-012026-07-23
A Comparison of Two Different Single Doses of Prednisolone on Endodontic Inter-appointment Pain
Prednisolone, lactose in capsules gelatin - Endodontics, Pain
Phase 2UnknownKing Saud University722020-08-092020-07-22
Efficacy of a Standardized Centella Asiatica Extract in Patients With Temporomandibular Disorder
ECa 233, Ibuprofen, Placebo - Temporomandibular Disorder
Phase 2 / Phase 3CompletedChulalongkorn University232020-08-052024-02-07
Mirtogenol and Bimatoprost on IOP in Hispanics With Open-Angle Glaucoma
Experimental: Oral Mirtogenol, Placebo of oral Dietary supplement - Glaucoma
Not applicableUnknownUniversity of Puerto Rico722020-05-152020-05-08
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel
Diphenhydramine, Cetirizine, Lactose pill - Breast Cancer, Lung Cancer
Phase 3CompletedCiusss de L'Est de l'Île de Montréal272020-02-142020-10-12

Showing 20 of 125. Sign in to see all of them.

Conditions studied

Pain (7)  ·  Anxiety Disorders (5)  ·  Pain, Postoperative (5)  ·  Alcoholism (3)  ·  Depression (3)  ·  Inflammation (3)  ·  Lactose Intolerance (3)  ·  Mental Disorders (3)  ·  Metabolic Syndrome (3)  ·  Obesity (3)  ·  Psychotic Disorders (3)  ·  Pulmonary Disease, Chronic Obstructive (3)  ·  Schizophrenia (3)  ·  Vitamin D Deficiency (3)  ·  Asthma (2)

Sponsors

University of Wisconsin, Madison (4)  ·  Centre for Addiction and Mental Health (3)  ·  Samuel Lunenfeld Research Institute, Mount Sinai Hospital (3)  ·  The Alfred (3)  ·  Biota Scientific Management Pty Ltd (2)  ·  Hospital Italiano de Buenos Aires (2)  ·  Mayo Clinic (2)  ·  Nantes University Hospital (2)  ·  Resilient Pharmaceuticals (2)  ·  Ullevaal University Hospital (2)  ·  Universidad Nacional Andres Bello (2)  ·  University Health Network, Toronto (2)  ·  University Hospital, Clermont-Ferrand (2)  ·  University of Toronto (2)  ·  Aga Khan University Hospital, Pakistan (1)

Countries

United States (40)  ·  Canada (20)  ·  France (11)  ·  United Kingdom (9)  ·  Australia (5)  ·  Norway (4)  ·  Belgium (3)  ·  Iran (3)  ·  South Korea (3)  ·  Argentina (2)  ·  Brazil (2)  ·  Chile (2)  ·  Denmark (2)  ·  Germany (2)  ·  Indonesia (2)

Top investigators

Jose CA Carvalho, MD (3)  ·  Bernard Le Foll, MD, PhD (2)  ·  Gaute Lyngstad, DDS (2)  ·  K. Rajender Reddy, MD (2)  ·  Mariely A Navarrete, MSc (2)  ·  Michael Fried, MD (2)  ·  Nezam Afdhal, MD (2)  ·  Victor Navarro, MD (2)  ·  Ahmaed Y Gamal (1)  ·  Ahmed S Mahmood, MSc (1)  ·  Allan L Reiss (1)  ·  Allan Struthers, MD FRCP (1)  ·  Andrei C Sposito, MD.PHD (1)  ·  Andrew Szilagyi, MD (1)

Results publications

PMID 15643744, PMID 31415936, PMID 12751655, PMID 16488940, PMID 18618008, PMID 21770996, PMID 22220591, PMID 22797645, PMID 22870441, PMID 22998754, PMID 23316132, PMID 23335901, PMID 23822797, PMID 24012319, PMID 24190578, PMID 24515444, PMID 24616831, PMID 24684534, PMID 24937541, PMID 24948402, PMID 25027286, PMID 25167977, PMID 25389003, PMID 25590214, PMID 25673981, PMID 25716971, PMID 25827058, PMID 25835160, PMID 26297500, PMID 26304941, PMID 26582405, PMID 27438995, PMID 28003052, PMID 28243404, PMID 28623320, PMID 30431582, PMID 30686636, PMID 30774444, PMID 31073924, PMID 31094746, PMID 31447547, PMID 31536511, PMID 32043983, PMID 32143990, PMID 32346093, PMID 32364251, PMID 32534337, PMID 32588430, PMID 32612617, PMID 32678530

NIH funding

2015 (4), 2008 (1), 2009 (1), 2014 (1), 2016 (1), P01HL069999 (1), P50DA018197 (1), P50MH099910 (1), P60AA003510 (1), R01DA047391 (1), R01DK073354 (1), R01HL073980 (1), R01HL179276 (1), R21AA019994 (1), R21MH138923 (1)